Suanfarma Suanfarma

X

SPRIO Imidazole HCl manufacturers and suppliers on PharmaCompass

PharmaCompass
SPRIO Imidazole HCl
Also known as: 151257-01-1, 2-n-butyl-1,3-diaza-spiro[4,4]non-1-en-4-one hydrochloride, 2-butyl-1,3-diaza-spiro[4.4]non-1-en-4-one hcl, 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one;hydrochloride, 1,3-diazaspiro[4.4]non-1-en-4-one, 2-butyl-, monohydrochloride, Mfcd03428357
Molecular Formula
C11H19ClN2O
Molecular Weight
230.73  g/mol
InChI Key
WWRHZLCKSVQRBG-UHFFFAOYSA-N

1 2D Structure

SPRIO Imidazole HCl

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one;hydrochloride
2.1.2 InChI
InChI=1S/C11H18N2O.ClH/c1-2-3-6-9-12-10(14)11(13-9)7-4-5-8-11;/h2-8H2,1H3,(H,12,13,14);1H
2.1.3 InChI Key
WWRHZLCKSVQRBG-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCC1=NC2(CCCC2)C(=O)N1.Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 151257-01-1

2. 2-n-butyl-1,3-diaza-spiro[4,4]non-1-en-4-one Hydrochloride

3. 2-butyl-1,3-diaza-spiro[4.4]non-1-en-4-one Hcl

4. 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one;hydrochloride

5. 1,3-diazaspiro[4.4]non-1-en-4-one, 2-butyl-, Monohydrochloride

6. Mfcd03428357

7. 2-butyl-1,3-diazaspiro(4.4)non-1-en-4-one Hydrochloride

8. 2-butyl-4-spirocyclopentane-2-imidazolin-5-one, Hcl

9. 1,3-diazaspiro[4.4]non-1-en-4-one, 2-butyl-, Hydrochloride (1:1)

10. 2-butyl-4-spirocyclopentane-2-imidazolin-5-one Hydrochloride

11. 2-n-butyl-1,3-diaza-spiro[4,4]non-1-en-4-one Hcl

12. Ec 424-560-4

13. Schembl535435

14. 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-onehydrochloride

15. Dtxsid10436477

16. 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one--hydrogen Chloride (1/1)

17. Akos015907796

18. Akos037643283

19. Ab15412

20. Ac-6864

21. Am90294

22. Cs-w014181

23. As-12497

24. Sy036928

25. B3291

26. Ft-0659370

27. 257b011

28. A809140

29. 2-butyl-1,3-diazaspiro[4,4]non-1-en-4-one Hcl

30. 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one Hcl

31. 2n-butyl-1,3-diazaspiro (4,4) Non-1-en-4 One Hcl

32. 2n-butyl-1,3-diazaspiro (4,4) Non-1-en-4-one Hcl

33. 2-butyl-1,3-diaza-spiro[4.4]non-1-en-4-one Hydrochloride

34. 2-butyl-1,3-diaza-spiro[4.4]non-1-en4-one Monohydrochloride

35. 2-butyl-1,3-diazaspiro[4,4]non-1-en-4-one Monohydrochloride

36. 2-butyl-1,3-diazaspiro[4.4]non-2-en-4-one Monohydrochloride

37. 2-(n-butyl)-1,3-diazaspiro[4.4]non-1-ene-4-one Hydrochloride

38. 2-butyl-1,3-diaza-spiro [4.4] Non-1-en-4-one Monohydrochloride

39. 2-n-butyl-1,3-diaza-spiro[4,4]non-1-en-4-onehydrochloride

40. 8-butyl-7,9-diazaspiro[4.4]non-8-en-6-one Hydrochloride;2-n-butyl-1,3-diaza-spiro[4,4]non-1-en-4-one Hcl

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 230.73 g/mol
Molecular Formula C11H19ClN2O
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count3
Exact Mass230.1185909 g/mol
Monoisotopic Mass230.1185909 g/mol
Topological Polar Surface Area41.5 Ų
Heavy Atom Count15
Formal Charge0
Complexity265
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
Flag India
Digital Content Digital Content
114772-54-2
Irbesartan
Soujanya Life Sciences is a new division of the Soujanya Group, a 40-year-old organization with a strong ...
Soujanya Life Sciences is a new division of the Soujanya Group, a 40-year-old organization with a strong presence in 50 countries and expertise in pigments and dyes. Soujanya Life Sciences combines the energy and optimism of a new venture with the proven credibility of the parent group. It manufactures sustainable and efficient APIs and advanced intermediates for various therapeutic categories, including antidiabetics, anti-hypertensives, antioxidants, anti-aging, vitamins, nutraceuticals, etc. The company has a R&D lab in Pune. It currently operates two state-of-the-art LL production sites and plans to set up additional sites in the future.
Flag India
Digital Content Digital Content

2-Butyl-1,3-Diazaspiro[4,4]Non-1-En-4-One HCl

URL Supplier Web Content
Irbesartan
Hoventa Pharma is in the business of manufacturing APIs for over three decades.We offer various kinds of ...
Hoventa Pharma is in the business of manufacturing APIs for over three decades.We offer various kinds of services in addition to supplies of APIs, we undertake long-term contracts for manufacturing intermediates and development of new Active Pharmaceutical Ingredients as per your requirement. We have a sharp focus on giving value added services to our customers cost effectively. We are supplying APIs to the global pharmaceutical companies in India and abroad since the last 3 decades. Some of our major customers operate in India and export to their products to other countries.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
114772-54-2
Irbesartan
Louis Pharmaceuticals Private Limited is an Advanced Intermediates Manufacturing firm. The Company is est...
Louis Pharmaceuticals Private Limited is an Advanced Intermediates Manufacturing firm. The Company is established in 2009 and has an integrated focus from various disciplines including R&D, Quality Control, Quality Assurance, Environment, Human Resource, DRA, and Manufacturing teams. Louis Pharma has ISO 9001:2015 certification, Maintaining cGMP standards and meeting the current US DMF requirements.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
114772-54-2
Irbesartan
Sanpra Synthesis strongly believes that with its expertise and innovative pharmaceutical business backgro...
Sanpra Synthesis strongly believes that with its expertise and innovative pharmaceutical business background, it is aptly positioned for APIs and intermediates manufacturing and outsourcing for the global market. We also undertake custom synthesis and contract manufacturing. Setting up multiple c GMP-manufacturing facility and world-class R&D center located in Vizag APSEZ De-notified area with well connected to road, rail, and air enabling cargo movement to the nearest transport facility in commercial production from January 2020.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
138401-24-8
Irbesartan
Sanpra Synthesis strongly believes that with its expertise and innovative pharmaceutical business backgro...
Sanpra Synthesis strongly believes that with its expertise and innovative pharmaceutical business background, it is aptly positioned for APIs and intermediates manufacturing and outsourcing for the global market. We also undertake custom synthesis and contract manufacturing. Setting up multiple c GMP-manufacturing facility and world-class R&D center located in Vizag APSEZ De-notified area with well connected to road, rail, and air enabling cargo movement to the nearest transport facility in commercial production from January 2020.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
138401-24-8
Irbesartan
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content

1-{2-cyanobiphenyl-4yl)methyl}-2-N-butyl-4-spirocyclope...

URL Supplier Web Content
138401-24-8
Irbesartan
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
114772-54-2
Irbesartan
Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise ...
Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise integrating drug research and development, production, and sales. It is located in Jinwan District, Zhuhai City, Guangdong Province. It was established in 1999. On January 5, 2018, the company was listed on the Shenzhen Stock Exchange (stock abbreviation: Rundu; stock code: 002923). The company's main business is the research and development, production, and sales of chemical-pharmaceutical preparations, chemical raw materials, and pharmaceutical intermediates. field.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY